Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Body composition, energy expenditure and physical activity

Proposed ratios and cutoffs for the assessment of lipodystrophy in HIV-seropositive individuals

Subjects

Abstract

Objectives:

To propose objective ratios using anthropometry and dual-energy X-ray absorptiometry (DXA) and to suggest cutoff points for them in order to classify lipodystrophy in male patients.

Methods:

It is a cross-sectional study. DXA was applied and anthropometric measurements were performed in 100 men on highly active antiretroviral therapy. Receiver operating characteristic curves were used to propose cutoffs. Individuals were divided in without (lipo−) or with (lipo+) lipodystrophy and their metabolic parameters were compared.

Results:

The following ratios were proposed: fat mass ratio by DXA (FMR), waist thigh ratio (WTR), waist calf ratio (WCR), and arm to trunk ratio (ATR). The best cutoffs observed for FMR, WTR and ATR were 1.26, 1.74 and 2.08, respectively. Using the proposed cutoff for FMR, we observed worse metabolic profile, with increased tryglicerides, fasting serum glucose and more hypercholesterolemia in the lipo+ group. WTR and ATR showed a significant correlation with FMR.

Conclusions:

Anthropometric ratios (WTR/ATR) and FMR can be used to aid the diagnosis of lipodystrophy in order to contribute to a more accurate and earlier diagnosis permitting intervention and even preventing metabolic disturbances.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Marins JRP, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS 2003; 17: 1675–1682.

    Article  Google Scholar 

  2. Boskurt B . Cardiovascular toxicity with highly active antiretroviral therapy: review of clinical study. Cardiovasc Toxicol 2004; 4: 243–260.

    Article  Google Scholar 

  3. Brown T, Wang Z, Chu H, Palela FJ, Kingsley L, Witt MD et al. Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr 2006; 43: 356–362.

    Article  Google Scholar 

  4. Torriani M, Thomas BJ, Barlow RB, Librizzi J, Dola NS, Grinspoon S . Increased intramyocellular lipid accumulation in HIV infected women with fat redistribution. Journal of applied physiology 2006; 100: 609–4.

    Article  Google Scholar 

  5. Baril JG, Junod G, Leblanc R, Dion H, Therrien R, Laplant F et al. HIV – associated lipodystrophy syndrome: a review of clinical aspects. J Infect Dis Med Microbiol 2005; 16: 233–243.

    Article  Google Scholar 

  6. Tershakovec A, Frank I, Rader D . HIV-related lipodystrophy and related factors. Atherosclerosis 2004; 174: 1–10.

    Article  CAS  Google Scholar 

  7. Bonnet E, Delpierre C, Sommet A, Mario-Latard F, Hervé R, Aquilina C et al. Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men. J Clin Densitom 2005; 8: 287–292.

    Article  CAS  Google Scholar 

  8. Freitas P, Santos AC, Carvalho D, Pereira J, Marques R, Martinez E et al. Fat mass ratio: an objective tool to define lipodystrophy in HIV-infected patients under antiretroviral. therapy. J Clin Densitom 2010; 13: 197–203.

    Article  Google Scholar 

  9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III – ATP III). JAMA 2001; 285: 2486–2497.

    Article  Google Scholar 

  10. Sutinen J, Yki-Jarvinen H . Increased resting energy expenditure, fat oxidation, and food intake in patients with highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol End Met 2007; 292: E687–E692.

    Article  CAS  Google Scholar 

  11. Lohman TG, Roche AF, Martorell R Anthropometric standardization reference manual. Human Kinetics Books: Champaign, 1988.

    Google Scholar 

  12. Lohman TG, Roche AF, Martorell R Anthropometric standardization reference manual: a bridged edition. Human Kinetics Books: Champaign, 1991, p 90.

    Google Scholar 

  13. Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D et al. From the Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Fat distribution in men with HIV Infection. J Acquir Immune Defic Syndr 2005; 40: 121e131.

    Google Scholar 

  14. Bedimo RJ . Body-Fat Abnormalities in Patients With HIV: Progress and Challenges. J Int Assoc Physicians AIDS Care 2008; 7: 292–305.

    Article  Google Scholar 

  15. Kosmiski L, Kuritzkes D, Hamilton J, Sharp T, Lichtenstien K, Hill J et al. Fat distribution is altered in HIV-infected men without clinical evidence of the HIV lipodystrophy syndrome. HIV Med 2003; 4: 235–240.

    Article  CAS  Google Scholar 

  16. Milinkovic A, Martinez E . Current perspectives on HIV-associated lipodystrophy syndrome. J Antimicrob Chemother 2005; 56: 6–9.

    Article  CAS  Google Scholar 

  17. Carr A, Emery S, Law MG, Puls R, Lundgren JD, Powderly W . An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. HIV Lipodystrophy Case Definition Study Group. Lancet 2003; 361: 726–735.

    Article  CAS  Google Scholar 

  18. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12: 51–58.

    Article  Google Scholar 

  19. Massip P, Marchou B, Bonnet E, Cuzin L, Montastruc JL . Lipodystrophy with protease inhibitors in HIV patients. Therapie 1997; 52: 615.

    CAS  PubMed  Google Scholar 

  20. Viraben R, Aquilina C . Indinavir-associated lipodystrophy. AIDS 1998; 12: 37–39.

    Article  Google Scholar 

  21. Beraldo RA, Vassimon HS, Jordão J. AA, Albuquerque FJ, Machado AM, Foss-Freitas MC et al. Anthropometry and bioelectrical impedance analysis compared to dual-photon absorptiometry for the assessment of body composition of hiv-seropositive patients. Rev Chil Nutr 2011; 38: 404–413.

    Article  Google Scholar 

  22. Weber RV, Buckley MC, Fried SK, Kral JG . Subcutaneous lipectomy causes a metabolic syndrome in hamsters. Am J Physiol Regul Integr Comp Physiol 2000; 279: 936–943.

    Article  Google Scholar 

  23. Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001; 32: 130–139.

    Article  CAS  Google Scholar 

  24. Barroso SG, Abreu VG, Francischetti EA . A Participação do Tecido Adiposo Visceral na Gênese da Hipertensão e Doença Cardiovascular Aterogênica. Um Conceito Emergente. Arq Bras Cardiol 2002; 78: 618–630.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank the Infectious Disease Ambulatory division of the Ribeirão Preto Medical School, University of São Paulo, Brazil. We would like to acknowledge Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) for partially supporting this research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R A Beraldo.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beraldo, R., Vassimon, H., Aragon, D. et al. Proposed ratios and cutoffs for the assessment of lipodystrophy in HIV-seropositive individuals. Eur J Clin Nutr 69, 274–278 (2015). https://doi.org/10.1038/ejcn.2014.149

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2014.149

This article is cited by

Search

Quick links